Evidence map›Paper›PMID 27547788›Full record

ArticleBio-protocol2014

Monoclonal Antibody Purification (

Adam Husk, Krystal Teasley Hamorsky, Nobuyuki Matoba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bio-protocol, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Production andFrontiers in plant science · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adam HuskOwensboro Cancer Research Program at James Graham Brown Cancer Center, University of Louisville School of Medicine, Owensboro, USA.
Krystal Teasley HamorskyOwensboro Cancer Research Program at James Graham Brown Cancer Center, University of Louisville School of Medicine, Owensboro, USA.
Nobuyuki MatobaDepartment of Pharmacology and Toxicology, and Owensboro Cancer Research Program at James Graham Brown Cancer Center, University of Louisville School of Medicine, Owensboro, USA.

Funding

Plant-produced Actinohivin as a Candidate HIV MicrobicideR33AI088585 · NIAID · UNIVERSITY OF LOUISVILLE · PI MATOBA, NOBUYUKI · 2012 to 2014
$1.3M
Plant-produced Actinohivin as a Candidate HIV MicrobicideR21AI088585 · NIAID · UNIVERSITY OF LOUISVILLE · PI MATOBA, NOBUYUKI · 2010 to 2011
$408k
NIAID NIH HHS R21 AI088585NIAID NIH HHS R33 AI088585
6 · The paper itself

Abstract

Plant-based expression systems provide an alternative biomanufacturing platform for recombinant proteins (Matoba

Identifiers

PMID27547788
PMCPMC4990144

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.